1928 Diagnostics - Distans/Flexibel - Heltid
Intervjun börjar direkt i ansökan – inget CV eller personligt brev.
Se statistik, din status i processen och antalet sökande.
As a Key Account Manager at 1928 Diagnostics, with EMEA as your market, you will have the opportunity to work in the dynamic environment of a start-up to apply your passion for sales and business development to give hospitals actionable insights on genetic data and defeat antibacterial resistance globally.
At the forefront of digital health, 1928 Diagnostics strives to bring the full value of Bioinformation Technology and Cloud Computing to revolutionize how health care fight antibiotic resistant bacteria. The company was elected a World Economic Forum Tech Pioneer in 2018.
As a KAM you will work to build a customer network within Microbiology and Infection control across Europe. The company is in the early commercialization phase where we are working to establish a user base and at the same time rapidly develop and the product in close collaboration with our users. You will report directly to the Director of Commercial Operations, and be encouraged to take a great responsibility and be innovative in how we reach and build the market.
To apply, please submit your CV and cover letter at email@example.com.
Deadline for application is 2019-09-15.
For more information regarding the position please contact:
Competent and fun colleagues
1928 is a Swedish company based in Gothenburg with strong ties to both the tech and science community, bridging knowledge from biology and medicine into software development. Our mission is to use technology to build important services that can be used in healthcare to address the growing and alarming problem of antimicrobial resistance. Sweden is our homebase, but we are operating globally, and look forward to meet you wherever our paths will cross.
Join us in the fight against antibiotic resistance!
We are a cross functional team of 14 people on a mission to fight one of today’s largest threats against human health, antibiotic resistance. By offering cloud software services that analyses DNA from infectious bacteria, we can help hospitals to track down antibiotic resistant bacteria and support the physician in choosing the correct antibiotic treatment for the patient and support outbreak management and surveillance.
The company was founded by three scientists and a serial entrepreneur in 2014. From 2019 an onwards we are commercializing our products globally. In 2018, 1928 Diagnostics was awarded as Technology Pioneer by World Economic Forum, for our innovative technology that is poised to have a significant impact on global health, society and business.
We have a strong team spirit and enjoy spending time together at the office. Working hours are flexible and working from home now and then is common. Delivering according to timelines is important. The organisation is flat and each person holds responsibility for their own work.
Apart from doing good for the world we also embrace openness, diversity, creativity, collaboration, new technology and having fun. We are continuously growing and looking for people with a positive attitude that get things done.